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Abstract
Background: Research efforts to measure the concept of healthy ageing have been di-
verse and limited to specific populations. This diversity limits the potential to compare
healthy ageing across countries and/or populations. In this study, we developed a novel
measurement scale of healthy ageing using worldwide cohorts.
Methods: In the Ageing Trajectories of Health-Longitudinal Opportunities and Synergies
(ATHLOS) project, data from 16 international cohorts were harmonized. Using ATHLOS
data, an item response theory (IRT) model was used to develop a scale with 41 items
related to health and functioning. Measurement heterogeneity due to intra-dataset
specificities was detected, applying differential item functioning via a logistic regression
framework. The model accounted for specificities in model parameters by introducing
cohort-specific parameters that rescaled scores to the main scale, using an equating
procedure. Final scores were estimated for all individuals and converted to T-scores with
a mean of 50 and a standard deviation of 10.
Results: A common scale was created for 343 915 individuals above 18 years of age from
16 studies. The scale showed solid evidence of concurrent validity regarding various
sociodemographic, life and health factors, and convergent validity with healthy life ex-
pectancy (r¼ 0.81) and gross domestic product (r¼ 0.58). Survival curves showed that
the scale could also be predictive of mortality.
Conclusions: The ATHLOS scale, due to its reliability and global representativeness, has
the potential to contribute to worldwide research on healthy ageing.
Key words: Healthy ageing, scale, functional ability, intrinsic capacity, item response theory, data integration
Key Messages
• This study used an item response theory approach to develop a common scale for measuring healthy ageing, based
on data harmonized and integrated from 16 international cohorts.
• The scale can measure the biopsychosocial aspects of health and functioning, since it covers domains of vitality, sensory
functions, locomotion, cognition and activities of daily living that imply interaction with the individual’s environment.
• The scale is intended to be universally applicable for evaluating healthy ageing, as it arises from the use of interna-
tional cohorts covering 38 countries from all populated continents.
• Notwithstanding efforts at integration, as far as we know, no other study has yet produced a common measurement
approach, based concomitantly on the combination of intrinsic capacity and functional ability, for assessing interna-
tionally healthy ageing.
• The development of this scale may help researchers and policy makers to have a better understanding of healthy
ageing and will move forward in epidemiological research of healthy ageing.
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Introduction
Population ageing poses enormous challenges to the social
welfare state as a result of greater needs for the elderly’s
health and social care.1,2 To address this issue, research ini-
tiatives have analysed the concept of healthy, active or suc-
cessful ageing internationally at several levels.3,4 However,
few of these research efforts have adequately tackled the
complex challenge of addressing the concept of healthy
ageing, since international consensus regarding how
healthy ageing should be measured, to account for the
diversity of populations globally, has not been achieved
to date.5–7 Existing indices or scores of healthy ageing
address different concepts and are limited to specific popu-
lations.4–9 Hence, efforts are needed to obtain a validated
universally applicable measurement tool.7
The World Health Organization (WHO) proposed in
2015 to define healthy ageing as an ‘ongoing process of de-
veloping and maintaining the functional ability that ena-
bles well-being in older age’.2,6 This framework has moved
away from focusing on the presence of disease experienced
at a single time point to considering healthy ageing as a
function of an individual’s functional ability over time.
Functional ability is determined by the interaction of indi-
viduals’ intrinsic capacity and their environment. In turn,
an individual’s intrinsic capacity is comprehensively con-
sidered by addressing all physical and mental capacities;
and the environment should at least include access to medi-
cations, personal support, assistive devices and physical
barriers that may be either facilitate or hinder functional
ability.10 To this effect, a measure which combines an indi-
vidual’s intrinsic capacity and functional ability may be
able to more broadly capture a person’s healthy ageing
level. In addition, such a measure may have the ability to
stimulate more effective prevention strategies by fostering
either intrinsic capacity or the resulting functional ability
through environmental interventions.
Epidemiological studies on ageing tend to collect het-
erogeneous information on biopsychosocial aspects of
health and functioning. Integrating data from multiple co-
hort studies can be a viable way to combine knowledge
gained with a sustainable methodology and provide a nu-
anced understanding of ageing in different populations. It
increases sample size and improves statistical power to ac-
curately estimate health outcomes and their determinants.
Additionally, it facilitates comparisons within and across
study populations due to variety in geography, composi-
tion, socioeconomic status and other factors of interest.
This provides significant opportunities for researchers to
pool data from multiple studies and conduct data analyses
simultaneously.11 Some key harmonization and integration
activities have been conducted as the Health and
Retirement Studies family, the Integrative Analysis of
Longitudinal Studies on Aging, or the WHO Study on
Global Ageing and Adult Health.12–14 Yet there is a need
to develop a common approach that will facilitate tempo-
ral and regional assessments of healthy ageing across di-
verse populations.
This study is based on the Ageing Trajectories of
Health-Longitudinal Opportunities and Synergies
(ATHLOS) project, which has produced a large harmo-
nized dataset from 38 countries from all populated conti-
nents.15 This study aims to develop a novel scale
measuring healthy ageing using items about intrinsic ca-
pacity and functional ability and to provide evidence of va-
lidity. The scale is intended to be universal, since
individual data from any one study can be used to estimate
healthy ageing scores comparable to all of them.
Methods
The study protocol was approved by the Committee on the
Ethics of Clinical Research, CEIC Fundació Sant Joan de
Déu (protocol number: PIC-22–15). All data were anony-
mized and electronic health record confidentiality was
respected in accordance with national and international
law.
Data sources
The ATHLOS cohort is composed of harmonized datasets
of international cohorts related to health and ageing. To
this effect, data from the following 16 studies were consid-
ered: the 10/66 Dementia Research Group Population-
Based Cohort Study (10/66)16 with waves 1 and 2; the
Australian Longitudinal Study of Aging (ALSA)17 from
wave 1 to 13; the China Health and Retirement
Longitudinal Study (CHARLS)18 with waves 1 and 2;
Collaborative Research on Ageing in Europe
(COURAGE)19 with waves 1 and 2; the English
Longitudinal Study of Ageing (ELSA)20 from wave 1 to 7;
Study on Cardiovascular Health, Nutrition and Frailty in
Older Adults in Spain (ENRICA)21 from wave 1 to 3; the
Health, Alcohol and Psychosocial factors in Eastern
Europe Study (HAPIEE)22 with waves 1 and 2; the Health
2000/2011 Survey (H2000/11)23 with waves 1 and 2; the
Health and Retirement Study (HRS)24 from wave 1 to 11;
the Japanese Study of Aging and Retirement (JSTAR)25
from wave 1 to 3, the Korean Longitudinal Study of
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Ageing (KLOSA)26 from wave 1 to 4; the pilot-study
Longitudinal Aging Study in India (LASI);27 the Mexican
Health and Aging Study (MHAS)28 from wave 1 to 3; the
Study on Global Ageing and Adult Health (SAGE)29 with
only wave 1; the Survey of Health, Ageing and Retirement
in Europe (SHARE)30 from wave 1 to 5; and the Irish
Longitudinal Study of Ageing (TILDA)31 with waves 1 and
2. The above studies include populations from 38 countries
across five continents.
The data harmonization aimed to transform study-
specific variables in a homogeneous definition and format
across studies.32 More detailed information about the har-
monization process in the ATHLOS project can be found
elsewhere.15
Intrinsic capacity and functional ability items
To develop the healthy ageing scale, the ATHLOS consor-
tium agreed on a comprehensive list of 41 items related to
intrinsic capacity and functional ability, covering the biop-
sychosocial aspects of health and functioning usually found
in general population surveys.33 All items were assessed
across studies and successfully harmonized in at least three
studies. Study-specific variables were harmonized into di-
chotomous items expressing the presence or absence of dif-
ficulties. Continuous variables were dichotomized in the
first quartile, indicating the presence of difficulties. The
harmonization process of each item can be found at
Supplementary Table S1, available as Supplementary data
at IJE online.
Data selection
The sample size used to construct the scale included all
individuals above 18 years of age. We selected all individu-
als with available data on at least one of the 41 items and
used their earliest observed assessment.
Statistical analysis
We developed the healthy ageing scale using item response
theory (IRT) models.34 We chose the two-parameter logis-
tic IRT model, where the probability of endorsing a re-
sponse category is modelled as a function of two item
parameters, item discrimination and item difficulty, and a
person parameter. To test the adequacy of the model as a
measurement scale, its fit was assessed using the Root
Mean Square Error of Approximation (RMSEA; good
fit<0.06), the Comparative Fit Index (CFI; good fit>0.95)
and the Tucker-Lewis index (TLI; good fit>0.95).35 The
initial estimation of item and person parameters (calibra-
tion) was obtained by applying full information maximum
likelihood estimation on the sample matrix of response
patterns. The score of each individual was calculated using
the expected a posteriori estimation method. Maximum
score reliability and model marginal reliability were
assessed.36
As each study had a different subset of available items,
differences between the scores on the scale and scores on
study-specific scales were assessed using intraclass correla-
tion coefficients (ICC). High ICC values indicate that the
scoring system is stable to obtain same person scores de-
spite different item subsets.
To establish the homogeneity of the scale across studies,
a logistic regression framework was used to detect differen-
tial item functioning (DIF), which indicates whether items
are measured in the same way for all studies.37 If a study
had any items exhibiting DIF, specific parameters were es-
timated applying the overall model in the study-specific
sample. To rescale specific parameters to the full sample,
scaling parameters were linearly moved using the Stocking-
Lord equating approach.38 Thus, the procedure took into
account study-specific IRT parameters for items with DIF
by equating study-specific parameters to the main scale us-
ing a test characteristic curve equating procedure.39 The
resulting scores were converted to T-scores with a mean of
50 and a standard deviation of 10. These constituted the fi-
nal healthy ageing scores of the sample based on the main
scale.
To check concurrent validity of the scale, weighted lin-
ear trends of the T-score means by age groups were
assessed for each study. Second, a multiple linear regres-
sion model was carried out to investigate whether the T-
scores were associated with known risk factors for poor
health in adulthood. The following variables were in-
cluded, which were all self-reported by the participant:
socidemographic variables such as country, sex, age, year
of birth, education and wealth; lifestyles such as smoking
and obesity; most frequent physician-diagnosed diseases
such as high blood pressure, cardiovascular disease, respi-
ratory disease, diabetes, joint disorders; one frequent disor-
der such as depression that was based on the psychometric
instrument of each study; and one important social envi-
ronment such as loneliness which was based in some stud-
ies on a symptom of the depression instrument and in
others on questions about the feeling of loneliness.
Variables with too many missing structural values were
avoided because some studies were not found or were not
valid to be harmonized. Predictive validity was supported
using the harmonized age at death variable in those studies
with follow-up and provided by each study. Kaplan-Meier
survival estimators of T-scores categorized into four
groups (less than or equal to 40, 41–50, 51–60 and 61 or
higher) and time from participant assessment to death
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were plotted. Finally, to check convergent validity,
each country’s T-score means were compared with
two established indicators for health and wealth: the
Healthy Life Expectancy (HALE) at birth and the Gross
Domestic Product (GPD) per capita, both from the year
2016 in each country.40 Potential sex, age and birth cohort
effects were previously removed by calculating the differ-
ence between T-scores and predicted T-scores from a linear
regression adjusted by sex, age, year of birth and their
interactions.
All analyses were conducted with the statistical soft-
ware R and appended as Supplementary materials, avail-
able as Supplementary data at IJE online.
Results
The sample size was 343 915 individuals, 55% were fe-
male and the median age was 60 years (see Table 1). This
sample size was 98.9% of the total eligible participants
who had information on at least one item. Of the remain-
ing 1.1% (3978 individuals), 60% were from the SAGE
study. Studies that provided the largest sample sizes were
SHARE (30.8%), SAGE (12.3%) and HRS (10.6%).
Years of interview were mostly between 2000 and 2015
except in ALSA and HRS, which started in the early 90s.
In HRS, new cohorts were refreshed over the years.
Medians of years of birth were between 1940 and 1950
except in the studies 10/66, ALSA and HRS, which in-
cluded individuals who were born earlier.
The IRT model converged successfully with an excellent
fit (RMSEA¼ 0.03, TLI¼ 0.99 and CFI¼ 0.99). The IRT
parameter estimates showed that daily activity items had
the highest values for discrimination and cognitive items
had the lowest values (see Table 2).
T-scores were computed for all the individuals, with
high scores indicating healthier ageing. The T-scores range
was from 12 to 69, left-skewed with a mean of 50.2 and a
standard deviation of 10. The model had maximum reli-
ability of 0.975 at the T-score 35.3, with reliability over
0.90 from T-scores 23.2 to 48.5, and a model marginal re-
liability of 0.83. ICCs between the T-scores for the main
scale and each study-specific subset of items were higher
than 0.89 (see Table S1).
Items with DIF were found in three or fewer studies, ex-
cept for the item ‘energy’ that presented DIF in 6 studies.
On the other hand, ENRICA, HRS, and MHAS were the
only studies without any items with DIF. All others exhib-
ited from 1 to 8 items with DIF. 10/66, ALSA and SAGE
were the studies with the highest proportion of items with
DIF (see Table S1).
Table 1 Descriptive statistics of sex, age, years of interview and birth by study of participants included in the construction of the
healthy ageing scale
Studies Sample size Females Age Years of interview Years of birth
N % % min med max min med max min med max
10/66 16886 4.9 62 65 73 110 2001 2005 2010 1896 1932 1944
ALSA 2087 0.6 49 64 78 103 1992 1992 1993 1889 1914 1927
CHARLS 20273 5.9 52 19 57 101 2011 2011 2013 1910 1954 1993
COURAGE 10780 3.1 57 18 60 104 2011 2011 2012 1903 1951 1994
ELSA 17984 5.2 55 19 59 94 2002 2002 2015 1908 1944 1987
ENRICA 2519 0.7 53 60 67 93 2008 2009 2010 1915 1941 1950
HAPIEE 26664 7.8 53 44 58 75 2002 2004 2008 1932 1945 1962
HRS 36320 10.6 56 18 56 103 1992 1994 2013 1890 1938 1992
H2000-11 8417 2.4 55 30 49 101 2000 2000 2012 1900 1951 1981
JSTAR 7105 2.1 52 46 63 77 2007 2007 2011 1930 1945 1964
KLOSA 10 254 3.0 57 45 61 105 2006 2006 2006 1901 1945 1961
LASI 1413 0.4 56 21 53 102 2010 2010 2010 1907 1956 1989
MHAS 19 848 5.8 44 18 57 114 2001 2001 2012 1895 1946 1992
SAGE 42 268 12.3 57 18 58 114 2007 2007 2010 1893 1949 1991
SHARE 105 829 30.8 56 22 62 104 2004 2011 2013 1900 1946 1991
TILDA 8463 2.5 56 49 62 82 2010 2010 2012 1930 1948 1961
All 343 915 100 55 18 60 114 1992 2007 2015 1889 1945 1994
10/66, 10/66 Dementia Research Group Population-Based Cohort Study; ALSA, Australian Longitudinal Study of Ageing; CHARLS, China Health and
Retirement Longitudinal Study; COURAGE, Collaborative Research on Ageing in Europe; ELSA, English Longitudinal Study of Ageing; ENRICA, Seniors-
ENRICA; HAPIEE, Health, Alcohol and Psychosocial factors In Eastern Europe study; HRS, Health and Retirement Study; H2000-11, Health 2000/2011 study;
JSTAR, Japanese Study of Aging and Retirement; KLOSA, Korean Longitudinal Study of Ageing; LASI, Longitudinal Aging Study in India; MHAS, Mexican
Health and Aging Study; SAGE, Study on Global Ageing and Adult Health; SHARE, Survey of Health, Ageing and Retirement in 20 countries from Europe;
TILDA, Irish Longitudinal study on Ageing; min, minimum; med, medium; max, maximum.
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In the linear transformation of the equating approach,
additive parameter estimates ranged from -0.15 to 0.11,
and the multiplicative parameter estimates ranged from
0.90 to 1.11. Studies without items with DIF had the same
scores (see Table S1).
In all studies, we observed that T-scores were lower in
each older group (see Figure 1). COURAGE and H2000/11
had the highest decreasing slopes, -6.2 and -7.0, respec-
tively, which indicate the number of T-score units that de-
creased in each older group.
Regarding the results of the multiple linear regression,
we found that males and/or individuals with higher educa-
tional level, greater wealth and never smoking had higher
T-scores. In contrast, obesity, arterial hypertension,
Table 2 List of domains and items related to functioning and health and their parameter estimates from the item response the-
ory (IRT) model
Domains Presence or absence of difficulties IRT parameter estimates and standard errors
Discrimination Difficulty
Cognition Memory 0.8332 (0.0059) 0.5914 (0.0065)
Immediate recalla 0.6325 (0.0049) 0.9731 (0.0092)
Delayed recalla 0.6714 (0.0051) 1.2130 (0.0100)
Verbal fluencya 0.6080 (0.0057) 1.6981 (0.0160)
Orientation in time 0.8449 (0.0078) 1.7307 (0.0155)
Processing speeda 0.5912 (0.0144) 1.9291 (0.0453)
Numeracya 1.0404 (0.0118) 1.9586 (0.0203)
Psychology symptoms Sleeping 0.8334 (0.0052) 0.5605 (0.0057)
Vitality Experiences some degree of pain 1.0616 (0.0059) 0.1463 (0.0042)
Having high level of energy 0.9119 (0.0054) 0.5781 (0.0054)
Urinary incontinence 1.0969 (0.0111) 2.3546 (0.0196)
Sensory functions Near vision 0.9438 (0.0061) 0.9104 (0.0069)
Far vision 1.2639 (0.0075) 1.1091 (0.0062)
Eyesight using glasses or lens as usual 0.9421 (0.0086) 1.5122 (0.0126)
Hearing in general 0.8212 (0.0067) 1.9818 (0.0151)
Hearing in a conversation 0.8426 (0.0107) 2.2121 (0.0262)
Locomotion/mobility Stooping, kneeling or crouching 2.4717 (0.0120) 0.5059 (0.0029)
Lifting or carrying weights 2.7130 (0.0134) 0.7834 (0.0031)
Climbing stairs 2.7327 (0.0137) 0.7940 (0.0031)
Getting up from sitting down 2.4166 (0.0125) 0.8256 (0.0035)
Walking by yourself and without any
equipment
3.1335 (0.0161) 0.8763 (0.0030)
Pulling or pushing large objects 3.1691 (0.0202) 0.8848 (0.0036)
Sitting for long periods 2.0455 (0.0114) 1.1322 (0.0047)
Reaching or extending arms 2.1929 (0.0129) 1.4727 (0.0054)
Walking speeda 0.8995 (0.0111) 1.6364 (0.0160)
Dizziness when walking on a level surface 1.3230 (0.0128) 1.7363 (0.0142)
Picking up things with fingers 2.3139 (0.0156) 1.8427 (0.0068)
Activities of daily living Getting in or out of bed 3.4954 (0.0239) 1.4949 (0.0044)
Bathing or showering 3.5997 (0.0253) 1.5996 (0.0045)
Getting dressed 2.6935 (0.0180) 1.6404 (0.0055)
Moving around the home 3.4746 (0.0271) 1.6976 (0.0053)
Using the toilet 3.5668 (0.0277) 1.7960 (0.0054)
Eating 3.0627 (0.0255) 2.0989 (0.0073)
Instrumental activities of
daily living
Doing housework 3.1663 (0.0185) 1.0530 (0.0035)
Shopping for groceries 4.3188 (0.0376) 1.3521 (0.0045)
Getting out of the house 3.4506 (0.0377) 1.3939 (0.0056)
Difficulties in preparing meals 3.8589 (0.0360) 1.5886 (0.0058)
Using a map 1.6814 (0.0149) 1.6329 (0.0108)
Managing money, bills or expenses 2.4045 (0.0266) 1.8498 (0.0107)
Taking medications 3.0022 (0.0311) 2.0162 (0.0096)
Making telephone calls 2.9271 (0.0332) 2.0392 (0.0108)
aItem was dichotomized in the first quartile indicating presence of difficulties.
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depression, physical diseases and loneliness were associ-
ated with lower T-scores (see Table 3).
The studies H2000/11, MHAS and TILDA did not pro-
vide mortality information for reasons of confidentiality,
and LASI and SAGE had available only one wave. In the
Kaplan-Meier estimations, mortality risk was higher for
each lower T-score group throughout the observed time
period. The group with the lowest T-scores had a 50% sur-
vival probability in 10 years and for the other groups it
was in at least 20 years (see Figure 2).
Graphical representations of T-scores by country show
that cohorts from Switzerland (mean of 56.5), Japan (55.6)
and Denmark (55.4) had the highest T-scores (see
Figure 3). In contrast, cohorts from Ghana (40.4), India
(40.7) and Russia (42.7) had the lowest T-scores.
Correlations between T-score means by country and eco-
logical country indicators were 0.81 with HALE and 0.58
with GDP (see Figure 4).
Discussion
In this study, we developed a scale for measuring healthy
ageing comprising 41 items of intrinsic capacity and func-
tional ability, by employing harmonized data from 16
international ageing cohorts. The IRT model resulted in ex-
cellent reliability (>0.90) in T-scores from 23.5 to 48.5,
with marginal reliability of 0.83, rendering the model ade-
quate for group comparisons. Concurrent validity of the
scale with sociodemographic, life and health factors, and
predictive validity with mortality, have shown that this scale
corresponds well with health status and could be potentially
useful for conducting international ageing research.
We found that the scale was related to HALE, which is
known to differ between countries. Regarding GDP, coun-
tries’ well-being is known to be a determinant of health.41
The fact that the scale is sensitive to differences in GDP be-
tween countries indicates that it is a potential health out-
come useful for aggregate comparisons. However, these
comparisons are perhaps most interesting when examining
what is left behind. For example, why do countries with a
high HALE, such as Spain or South Korea, or with a high
GDP, such as the USA or Ireland, show worse ageing out-
comes than countries such as Denmark or Peru? Such
observations provide the basis for further studies and
thought-provoking hypotheses. Unfortunately, they are far
beyond the scope of this study.
Several scales are currently available for measuring spe-
cific aspects of health and ageing, albeit none concomitantly
Figure 1 Trends of healthy ageing T-scores by age groups in each study
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Table 3 Multiple linear regression between the T-scores of the healthy ageing scale and sociodemographic, life and health fac-
tors, adjusted by countrya
Variables Mean (SDb) or % Standardized coefficients 95% confidence interval
Age 62 (12) 4.25 (-4.36, -4.15)
Year of birth 1944 (13) 1.65 (-1.76, -1.54)
Age x year of birth  0.30 (0.28, 0.31)
Sex (reference: females) 55 0 
Males 44 0.83 (0.81, 0.86)
Missing 1 0.10 (-0.13, -0.07)
Education (reference: less than primary) 13 0 
Primary 22 0.25 (0.21, 0.30)
Secondary 43 1.04 (0.99, 1.09)
Tertiary 15 1.27 (1.23, 1.31)
Missing 7 0.42 (-0.46, -0.39)
Wealth c (reference: 1st quintile ¼ less wealthy) 18 0 
2nd quintile 16 0.18 (0.15, 0.21)
3rd quintile 17 0.34 (0.31, 0.37)
4th quintile 17 0.51 (0.48, 0.54)
5th quintile 18 0.75 (0.71, 0.78)
Missing 14 0.53 (0.49, 0.58)
Smoking (reference: never) 49 0
Past 23 0.14 (-0.17, -0.11)
Currently 20 0.33 (-0.36, -0.30)
Missing 8 0.24 (0.20, 0.28)
Obesity (reference: no) 66 0 
Yes 17 0.66 (-0.69, -0.64)
Missing 17 0.68 (0.63, 0.72)
Arterial hypertension (reference: no) 54 0 
Yes 36 0.33 (-0.35, -0.30)
Missing 10 0.35 (-0.39, -0.30)
Depression (reference: no) 70 0 
Yes 19 2.05 (-2.08, -2.02)
Missing 11 1.45 (-1.48, -1.41)
CVDd (reference: no) 83 0 
Yes 14 1.23 (-1.26, -1.20)
Missing 3 0.33 (0.29, 0.36)
Respiratory diseasee (reference: no) 89 0 
Yes 9 0.76 (-0.79, -0.74)
Missing 2 0.08 (-0.12, -0.04)
Diabetes (reference: no) 66 0 
Yes 11 0.52 (-0.55, -0.49)
Missing 23 0.52 (0.48, 0.56)
Joint disordersf (reference: no) 69 0 
Yes 22 1.70 (-1.73, -1.67)
Missing 9 0.60 (-0.66, -0.55)
Loneliness (reference: no) 57 0 
Yes 17 0.55 (-0.58, -0.52)
Missing 26 0.004 (-0.044, 0.036)
Adjusted R-squaredg ¼ 0.42
aVariable ‘country’ is categorical with 38 countries.
bSD: standard deviation.
cWealth: quantiles of household incomes and asset information from participants within their country cohort.
dAt least one of the following cardiovascular diseases (CVD): angina, stroke, myocardial infarction, heart attack, coronary heart disease, congestive heart
failure, heart murmur, valvular disease, cerebral vascular disease.
eAt least one of the following respiratory diseases: asthma, chronic obstructive pulmonary disease, bronchitis, emphysema.
fAt least one of the following joint disorders: arthritis, rheumatism, osteoarthritis.
gR-squared refers to the coefficient of determination.
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including the comprehensive assessment of intrinsic capac-
ity and functional ability. For example, the WHODAS 2.0
scale has been widely used to assess individual disability at
population levels or in clinical practice.42 However, it fo-
cuses on the individual’s functioning in interaction with
the social environment, thus assessing the functional ability
of a person rather than intrinsic capacity. Similarly, the
Active Ageing Index, which covers diverse aspects of active
and healthy ageing particularly in European populations,
focuses on individuals’ functional ability as well as interac-
tion with social and labour environments, rather than on
intrinsic capacity.8 On the other hand, a recent composite
ageing measure arising from the ELSA study included only
intrinsic capacity.9 The latter showed predictive capacity
for measuring an individual’s functioning, thus separating
the concepts of intrinsic capacity and functional ability.
Hence, the available scales are limited to specific popula-
tions and separate or merge some aspects of intrinsic ca-
pacity and functional ability with other domains used to
describe ageing: for instance, physiological and physical
health, personal perception and social environment, among
others. It must be underlined that most existing cohort
studies were not designed to measure intrinsic capacity and
functional ability separately. For example, self-reported vi-
sion problems might reflect both intrinsic capacity (those
who do not use glasses) and functional ability (those who
use glasses). Therefore, it is more appropriate to incorpo-
rate all measures related to intrinsic capacity and func-
tional ability, to capture healthy ageing when using
existing cohort data.
The ATHLOS scale was based on the IRT modelling
framework that allows for estimating item parameters that
are independent of person scores in the sample from which
they are obtained.34 This entails that individual scores
from the IRT measurement scale are comparable between
individuals from different studies responding to different
item subsets. Moreover, even though measurement biases
can occur, IRT modelling allows testing and adjusting the
effect of potential confounders on individual responses,
such as specific effects of cohorts, gender and cultural fac-
tors. Using modelling differential item functioning, it is
possible to obtain directly comparable measures across
groups.43,44 IRT also provides the means to scores in a uni-
versal reference, yielding the possibility of rescaling indi-
vidual scores obtained in a group to an arbitrary reference
scale of choice.43,45
Figure 2 Kaplan-Meier curves of healthy ageing T-scores categorized into four groups (<40, 40–49, 50–59, >60) and time from participant assessment
to death
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Methodological attempts to create the scale with similar
subsets of items were successfully conducted by using only
some specific studies within the ATHLOS project.46–49
However, the integration of multiple independent samples
in the ATHLOS dataset had the challenge of obtaining and
harmonizing a large number of intrinsic capacity and func-
tional ability items that are difficult to collect with individ-
ual samples. Having information about many items makes
it more feasible to capture the diverse heterogeneity of the
individual’s healthy ageing. Moreover, the IRT model
overcomes the potential obstacle of the presence of incom-
plete data, wherein some items serve as anchors for equat-
ing responses in different studies.50 Scores of individuals
from smaller subsets of items should obtain the score esti-
mates with the full subset of items, but with higher mea-
surement error. Nevertheless, the ICC that was conducted
showed that the scoring with different subsets of items was
well correlated to scores from the main scale. Furthermore,
in the case of choosing a subset of items for a new study,
priority should be given to those with the highest IRT dis-
crimination parameters, such as ADL/IADL (activities of
daily living, instrumental activities of daily living) items.
Using these items, it would be possible to establish a
minimum set of information for measuring the ageing sta-
tus of individuals.
Our results must be interpreted taking into account that
observational data can introduce selection and information
biases. The data come from the general population and
therefore the scale may under-represent people with
greater dependency living in nursing homes or other facili-
ties, or with greater cognitive impairment. These biases
can be aggravated when integrating data from studies with
different sampling designs, questionnaires and ways of ask-
ing for the same information. In addition, the harmoniza-
tion process had to address multiple issues of heterogeneity
across studies. Items had to be dichotomized to include the
maximum number of items per study. For instance, similar
questions with different levels required choosing the cut-
off point for dichotomization. Harmonizing questions
addressing the same type of difficulty (e.g. sleep was rest-
less versus difficulty sleeping) was more difficult. For this
reason, potential sources of DIF are usually studied by sub-
groups as a means of detecting heterogeneity when obtain-
ing an item. Future research should address other potential
sources of DIF such as sex and age, even though in prelimi-
nary analyses there were already very few items with DIF.
Figure 3 Distributions of healthy ageing T-scores by country
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From the list of 41 items covering the biopsychosocial
aspects of health and functioning, others may be missing
such as lung function, grip strength or even biomarkers of
immune function. These items, which may already be quite
correlated with the items included, are usually less com-
mon and would therefore add more complexity to the
scale. Other items more related to depressive/anxious men-
tal health symptoms, such as as feelings of sadness or lone-
liness, were considered candidates for inclusion in the
scale. However, in carrying out the analyses, these ele-
ments introduced new dimensions related to psychopathol-
ogy. As it would have been more difficult to interpret a
single measure of ageing, we chose to exclude these items
from the scale, leaving them aside for further research for
the diagnosis of affective disorders in ageing studies.
Healthy ageing scores have become useful tools in daily
clinical practice for patient prognosis, as well as for the de-
velopment of future public health strategies with the glob-
ally rapid pace of ageing. It is a fact that accuracy is the
cornerstone of this kind of score, so the wide use of a scale
like this in populations with divergent ethnic, genetic, so-
cial and cultural characteristics, and hence variable risk
factors, could lead to a specific variability in the prediction
of healthy ageing. However, through our methodological
approach, the accuracy and the validity of the healthy age-
ing estimation models, using multinational populations
and using different variables, represents an important topic
in the field of healthy ageing and is the first step towards
understanding the complex process of ageing.
We believe that the development of this scale will
make it possible to move forward the epidemiological re-
search of healthy ageing. This single scale can then be
used across studies conducted internationally. When ap-
plied to longitudinal data, these scores may provide reli-
able measures of healthy ageing scores over time. In this
way, the ATHLOS scale can identify patterns of healthy
ageing trajectories and their determinants, and critical
points in time when changes in trajectories are induced,
enabling the design and implementation of timely clinical
and public health interventions to optimize and promote
healthy ageing.
All the studies included in the ATHLOS project gave
permission for the secondary use of their data by the
ATHLOS Consortium. Data may be shared on request to
the corresponding author with permission of the ATHLOS
consortium.
Figure 4 Healthy ageing T-score means by country compared with the indicators ‘healthy life expectancy’ and ‘gross domestic product’, respectively
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